(Adds details on flu vaccine efforts, R&D plans, updates share price.) By Jon Kamp Of DOW JONES NEWSWIRES Baxter International Inc. (BAX...
(Adds details on outlook for business units, R&D efforts, updates share price.) By Jon Kamp Of DOW JONES NEWSWIRES Baxter International Inc...
Drug companies rushing to meet year-end targets to apply for U.S. regulatory approval of new drugs might want to slow down. The Food and Drug...
(Updates with comments from Baxter executives and fresh share price) By Jon Kamp Of DOW JONES NEWSWIRES Baxter International Inc. (BAX) issued...
By Jon Kamp Of DOW JONES NEWSWIRES Baxter International Inc. (BAX) issued long-range financial goals on Wednesday that continue to target...
CSL Ltd. (CSL.AU), the world's second-largest maker of human plasma products, said Wednesday full-year net profit rose 63% boosted by flu vaccine...
By Jon Kamp Of DOW JONES NEWSWIRES A Baxter International Inc. (BAX) hospital customer has filed suit in federal court alleging that Baxter and a...
BASEL (AFP)--The swine flu virus has set the laboratories and factories of Swiss pharmaceutical giants working all-out in the difficult search for...
The European Medicines Agency's Committee for Medicinal Products for Human Use, or CHMP, announced Friday positive opinions for new medicines from...
GlaxoSmithKline PLC (GSK.LN) Wednesday said it secured orders for 195 million doses of a new swine flu vaccine and expects to receive...
By Kate Gibson The U.S. stock market faces a massive onslaught of earnings in the days ahead, after getting a major lift from surprisingly upbeat...
Federal health officials said Friday they are planning to test H1N1 influenza vaccines that contain additional material known as adjuvants in...
(Updates throughout with more details on second-quarter results, guidance, comments from company and analyst, updated stock price.) By Jon Kamp Of...
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.